Lasalocid A Sodium
-
Catalog numberB1587-5
-
PricePlease ask
-
Size5 mg
-
-
Alternative_name6-[(3R,4S,5S,7R)-7-[(2S,3S,5S)-5-Ethyl-5-[(2R,5R,6S)-5-ethyltetrahydro-5-hydroxy-6-methyl-2H-pyran-2-yl]tetrahydro-3-methyl-2-furanyl]-4-hydroxy-3,5-dimethyl-6-oxononyl]-2-hydroxy-3-methylbenzoic acid sodium salt; X537A
-
DescriptionLasalocid is an antibiotic from the group of carboxylic ionophores, produced by Streptomyces lasaliensis. It displays anticancer properties and induces cytotoxic apoptosis and cytoprotective autophagy through reactive oxygen species (ROS) in human prostate cancer PC-3 cells.
-
CAS Number25999-20-6
-
Structure AvailableYes
-
Molecular FormulaC₃₄H₅₃NaO₈
-
Molecular Weight612.77
-
Cell Permeableyes
-
Purity≥94%
-
HandlingProtect from air and moisture
-
Tag LineAn anticancer agent
-
Storage Condition-20°C
-
Shipping ConditionGel Pack
-
Shelf Life36 months
-
MDL NumberMFCD00242774
-
PubChem CID6426773
-
SMILESCCC(C1C(CC(O1)(CC)C2CCC(C(O2)C)(CC)O)C)C(=O)C(C)C(C(C)CCC3=C(C(=C(C=C3)C)O)C(=O)[O-])O.[Na+]
-
InChiInChI=1S/C34H54O8.Na/c1-9-25(31-21(6)18-34(11-3,42-31)26-16-17-33(40,10-2)23(8)41-26)30(37)22(7)28(35)19(4)12-14-24-15-13-20(5)29(36)27(24)32(38)39;/h13,15,19,21-23,25-26,28,31,35-36,40H,9-12,14,16-18H2,1-8H3,(H,38,39);/q;+1/p-1/t19-,21+,22+,23+,25+,26-,28+,31+,33-,34+;/m1./s1
-
InChi KeyRDHDUYAKDYQPEW-HWLWSTNVSA-M
-
MSDS AvailableYes
-
Gene target
-
Short nameLasalocid A Sodium
-
Alternative nameLasalocid A Sodium
-